{"cik":1986247,"taxonomy":"us-gaap","tag":"AmortizationOfIntangibleAssets","label":"Amortization of Intangible Assets","description":"The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.","entityName":"Park Ha Biological Technology Co., Ltd.","units":{"USD":[{"start":"2022-11-01","end":"2023-10-31","val":992,"accn":"0001213900-25-016603","fy":2024,"fp":"FY","form":"20-F","filed":"2025-02-24","frame":"CY2023"},{"start":"2023-11-01","end":"2024-04-30","val":488,"accn":"0001213900-25-080494","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-08-26"},{"start":"2023-11-01","end":"2024-10-31","val":974,"accn":"0001213900-25-016603","fy":2024,"fp":"FY","form":"20-F","filed":"2025-02-24"},{"start":"2023-11-01","end":"2024-10-31","val":974,"accn":"0001213900-26-021984","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-02"},{"start":"2023-11-01","end":"2024-10-31","val":974,"accn":"0001213900-26-048728","fy":2025,"fp":"FY","form":"20-F/A","filed":"2026-04-29"},{"start":"2023-11-01","end":"2024-10-31","val":974,"accn":"0001213900-26-057152","fy":2025,"fp":"FY","form":"20-F/A","filed":"2026-05-15","frame":"CY2024"},{"start":"2024-11-01","end":"2025-04-30","val":482,"accn":"0001213900-25-080494","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-08-26"},{"start":"2024-11-01","end":"2025-10-31","val":970,"accn":"0001213900-26-021984","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-02"},{"start":"2024-11-01","end":"2025-10-31","val":970,"accn":"0001213900-26-048728","fy":2025,"fp":"FY","form":"20-F/A","filed":"2026-04-29"},{"start":"2024-11-01","end":"2025-10-31","val":970,"accn":"0001213900-26-057152","fy":2025,"fp":"FY","form":"20-F/A","filed":"2026-05-15","frame":"CY2025"}]}}